PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

2025-04-18
(Press-News.org) PHILADELPHIA, PA (April 17, 2025) – A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for individuals living with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments. The Monell team and colleagues identified that GLP-1 receptor agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as a promising therapeutic for managing the metabolic complications associated with BBS.

They used a genetically engineered mouse model of BBS that displayed the hallmark features of the condition, including excessive eating, impaired glucose regulation, behavioral deficits, and disrupted hormonal function. Remarkably, treatment with a GLP-1 receptor agonist (such as Ozempic® and Wegovy®) significantly reduced food intake, caused weight loss, improved glucose tolerance, and normalized metabolic hormone levels in the animals.

“Our findings suggest that GLP-1-based therapies effectively target gut and brain pathways involved in feeding and metabolism, even in the context of a complex genetic disorder like BBS,” said first author Arashdeep Singh, PhD, former Monell Research Associate. “This offers a much-needed treatment option for an underserved population.” Singh now holds the position of Scientist at Research Diets, Inc. located in New Brunswick, NJ.

Unique Model Gives Hope
The BBS mice are a fair approximation of the disease in humans. Specifically, their white fat tissue had immune cells more prone to inflammation and dysfunctional anti-inflammatory T cells, suggesting a different mechanism for weight gain compared to typical obesity animal models. In addition, BBS mice exhibited enlarged pancreatic islet cells, suggesting defective control of insulin levels in the circulatory system. The dysregulated molecular pathways they found also confirmed the cell-to-cell communication defects with insulin, leptin, and other hormones, yet at the same time preserving GLP-1R’s normal function.

Crucially, when BBC mice were given a GLP-1R, it effectively alleviated overeating, lessened body weight gain, improved glucose tolerance, and normalized circulating metabolic hormones. Overall, the study establishes two reasons for hope for a BBS treatment: one, BBS mice are a valuable model of this rare disease to understand its pathology and develop better treatments and two, the team’s findings highlight the therapeutic potential of GLP-1R agonists for managing BBS-associated metabolic dysregulation, warranting further investigation for clinical application.

Despite the promise of this research, real-world access to treatment remains a major challenge. The authors note that in conversations with physicians, they encountered hesitancy in prescribing GLP-1 therapies to BBS patients, largely due to a lack of clinical trial data. Many patients, especially in the United States, also face additional systemic barriers, such as restrictive health insurance coverage rules. BBS has a prevalence in North America and Europe of 1 in 140,000 to 1 in 160,000 newborns.

“This study represents a significant step forward in closing the treatment gap for BBS and demonstrates how targeting central satiety pathways with GLP-1 therapies may benefit patients whose conditions have long lacked effective medical options,” said senior author Guillaume de Lartigue, PhD, Monell Associate Member.

This study was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK116004, R01 DK094871) and an American Heart Association postdoctoral fellowship (23POST1026084).

About the Monell Chemical Senses Center
The Monell Chemical Senses Center is an independent nonprofit research institute in Philadelphia, Pennsylvania. It was founded in 1968 to advance and share discoveries in the science of the chemical senses of smell, taste, chemesthesis, and interoception to solve the world’s health, societal, and environmental challenges.
LinkedIn | Facebook | Instagram | X | YouTube

END


ELSE PRESS RELEASES FROM THIS DATE:

Scientists probe the mystery of Titan’s missing deltas

2025-04-18
PROVIDENCE, R.I. [Brown University] — For scientists who want to learn about the geological history of a planet, river deltas are a great place to start. Deltas gather sediment from a large area into one place, which can be studied to reveal climate and tectonic histories or signs of past life. That’s why NASA sent its most recent Mars rover to Jezero Crater, home to a prominent and well-preserved delta.  And that’s why planetary scientists are also interested in finding deltas on Saturn’s moon Titan. Titan is the only planetary body ...

Q&A: What makes an ‘accidental dictator’ in the workplace?

2025-04-18
UNIVERSITY PARK, Pa. — The professional world has no shortage of micromanagers — or, as Penn State School of Labor and Employment Relations (LER) faculty members Craig L. Pearce and Hee Man Park like to call them, “accidental dictators.” But leaders don’t have to fall into that trap, according to an article published in the journal Organizational Dynamics co-written by Pearce, Brova Family Endowed Professor of leadership and human resources, and Park, associate professor of human resource management and director of LER’s graduate program. The journal’s readership is largely made up ...

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

2025-04-18
Lehigh University Senior Research Scientist Arup K. SenGupta, a professor emeritus in the Department of Civil and Environmental Engineering, is the 2025 recipient of the Simon W. Freese Environmental Engineering Award and Lecture, presented by the American Society of Civil Engineers (ASCE). SenGupta, an ASCE Fellow, is an internationally recognized water scientist whose research has led to sustainable solutions for removing arsenic, fluoride, and other contaminants from drinking water around the world. His pioneering work in ion exchange science has also advanced technologies for desalination, wastewater reclamation, and carbon ...

Study highlights gaps in firearm suicide prevention among women

2025-04-18
Just under 4 in 10 women who died by firearm suicide had no documented history of mental or physical health problems in a new study, highlighting a need for prevention strategies tailored to at-risk women. The findings come at a time when suicides have been on the rise, alongside a surge in gun ownership — especially among women, said lead author Laura Prater, an assistant professor in The Ohio State University College of Public Health. In the last two decades, firearm deaths in the U.S., including those involving suicide, increased by almost 50%. Women historically made up 10 to 20% of new gun owners, a percentage ...

People with medical debt five times more likely to not receive mental health care treatment

2025-04-18
People with medical debt in 2023 were about five times more likely to forgo mental health care treatment in the following year due to cost, compared to those without medical debt, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. For their study, the researchers analyzed 2023 and 2024 data from a nationwide survey related to mental health. The researchers found that 33.8% of respondents who reported having had medical debt in 2023 also reported forgoing mental health care for cost-related reasons in 2024, compared ...

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

2025-04-18
Background and Aims Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis showed that adding hydronidone to entecavir resulted in significant reversal of liver fibrosis. To further evaluate the efficacy of a 270 mg/day dose of hydronidone for treating liver fibrosis associated with CHB, we conducted ...

Rise in claim denial rates for cancer-related advanced genetic testing

2025-04-18
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. The analysis by Georgetown University researchers and colleagues, and funded by a grant from the National Cancer Institute at the National Institutes of Health, appears April 18, 2025, in JAMA Network Open. The researchers point to several possible ...

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

2025-04-18
About The Study: In this serial cross-sectional study of adolescents in grades 7 to 11, legalization of cannabis edibles and extracts was associated with an increase not only in edible cannabis use and cannabis smoking, but also in the overall prevalence of cannabis use and co-use of alcohol and cannabis, highlighting the need for stricter policy measures to curb adolescents’ access to cannabis edibles and extracts and greater awareness among adolescents about harms of cannabis use. Corresponding ...

Medical debt and forgone mental health care due to cost among adults

2025-04-18
About The Study: In this survey study, more than 1 in 7 adults reported carrying medical debt in 2023, of whom 1 in 3 forwent mental health care in the subsequent year. Medical debt may exacerbate the treatment gap by potentially (1) raising the threshold for seeking care, (2) eroding patient trust in the health system, or (3) being denied care due to outstanding debts. Corresponding Author: To contact the corresponding author, Catherine K. Ettman, PhD, email cettman1@jh.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2025.0383) Editor’s ...

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

2025-04-18
Colder temperatures are linked with increased risk of diarrhea among Rohingya refugees in Bangladesh, emphasizing the need for climate-sensitive health strategies in refugee settings. A new study by scientists at Hokkaido University has found that lower temperatures significantly increase the risk of gastroenteritis among Rohingya refugees living in Bangladesh’s Kutupalong and Nayapara camps. Gastroenteritis is a viral or bacterial infection that causes inflammation of the stomach and intestines, resulting in ...

LAST 30 PRESS RELEASES:

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: May 9, 2025

Stability solution brings unique form of carbon closer to practical application

New research illustrates the relationship between moral outrage on social media and activism

New enzyme capable of cleaving cellulose should revolutionize biofuel production

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings

Chimpanzee groups drum with distinct rhythms

Wasp mums use remarkable memory when feeding offspring

Americans’ use of illicit opioids is higher than previously reported

Estimates of illicit opioid use in the U.S.

Effectiveness and safety of RSV vaccine for U.S. adults age 60 or older

Mass General Brigham researchers share tool to improve newborn genetic screening

Can frisky flies save human lives?

Heart rhythm disorder traced to bacterium lurking in our gums

American Society of Plant Biologists names 2025 award recipients

Protecting Iceland’s towns from lava flows – with dirt

Noninvasive intracranial source signal localization and decoding with high spatiotemporal resolution

A smarter way to make sulfones: Using molecular oxygen and a functional catalyst

Self-assembly of a large metal-peptide capsid nanostructure through geometric control

Fatty liver in pregnancy may increase risk of preterm birth

World record for lithium-ion conductors

Researchers map 7,000-year-old genetic mutation that protects against HIV

KIST leads next-generation energy storage technology with development of supercapacitor that overcomes limitations

Urine, not water for efficient production of green hydrogen

Chip-scale polydimethylsiloxane acousto-optic phase modulator boosts higher-resolution plasmonic comb spectroscopy

Blood test for many cancers could potentially thwart progression to late stage in up to half of cases

Women non-smokers still around 50% more likely than men to develop COPD

AI tool uses face photos to estimate biological age and predict cancer outcomes

North Korea’s illegal wildlife trade threatens endangered species

Health care workers, firefighters have increased PFAS levels, study finds

Turning light into usable energy

[Press-News.org] Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome